FDA OKs Two Gene-Editing Therapies for Sickle Cell Disease : vimarsana.com

The approval for the two gene-editing treatments, called exa-cel and lovo-cel, could help thousands with the blood disorder.

Related Keywords

United States , American , Roberta Brodsky , Franco Locatelli , Nicole Verdun , Johns Hopkins University School Of Medicine , Sapienza University Of Rome , Vertex Pharmaceuticals , Drug Administration , American Society Of Hematology , Crispr Therapeutics , Johns Hopkins University School , American Society , Biologics Evaluation , Sapienza University , Genomics Genomic Medicine , Sickle Cell Disease , Ickle Cell Anemia Sickle Anaemia , Blood , Lysosomal Storage Disease , Blood Transfusion , I Cell Disease , Ucolipidosis Type Ii , Nclusion Cell Disease , Ucolipidosis Ii , Ol Ii , Transplantation Of Stem Cells , Ransplantation Of Hematopoietic Stem Cells , Hematopoietic Stem Cell Transplant , Stem Cell Transplantation , Stem Cell Therapy ,